Literature DB >> 1702182

[The characters of AFP-producing early gastric cancer].

Y C Chang1, N Nagasue, S Abe, H Kohno, A Yamanoi, M Uchida, T Nakamura.   

Abstract

During the last decade, we have experienced 525 cases of gastric cancer. Within these, 195 were early gastric cancer (37.1%). Five and eight year survival rates were 86.9 and 77.2%. There were seven cases of recurrence, all of which were liver metastasis of submucosal cancers. Two combined with pulmonary metastasis. Three of the recurrent cases had serum AFP raised (greater than 20ng/ml) before or after partial gastrectomy. When these gastric specimens were reviewed, AFP positive cells were stained by PAP method. Compared with the AFP negative group of 168 early gastric cancers, invasion of lymphatic and venous vessels of the stomach and incidence of the liver metastasis were significantly higher in the stained group. 1.3 and 4.5 year survival rates of the cases (including ours) of AFP producing early gastric cancer, which had been reported in Japanese literatures, were 76.1, 45.7 and 22.9%, respectively. Liver metastasis was found in 7 of 12 cases (58.3%). It is clear that AFP producing early gastric cancer has the same tendency for liver metastasis as the AFP producing advance gastric cancer does. To prevent its recurrence, early diagnosis by PAP method for specimens with hepatic picture and aggressive adjuvant chemotherapy are mandatory.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1702182

Source DB:  PubMed          Journal:  Nihon Geka Gakkai Zasshi        ISSN: 0301-4894


  8 in total

1.  Clinicopathological and prognostic characteristics in patients with AFP-secreting gastric carcinoma.

Authors:  Yakup Bozkaya; Nebi Serkan Demirci; Alican Kurtipek; Gökmen Umut Erdem; Nuriye Yildirim Ozdemir; Nurullah Zengin
Journal:  Mol Clin Oncol       Date:  2017-06-08

2.  Liver metastasis is the only independent prognostic factor in AFP-producing gastric cancer.

Authors:  Shoji Hirajima; Shuhei Komatsu; Daisuke Ichikawa; Takeshi Kubota; Kazuma Okamoto; Atsushi Shiozaki; Hitoshi Fujiwara; Hirotaka Konishi; Hisashi Ikoma; Eigo Otsuji
Journal:  World J Gastroenterol       Date:  2013-09-28       Impact factor: 5.742

3.  Clinicopathological characteristics and prognosis of alpha-fetoprotein positive gastric cancer in Chinese patients.

Authors:  Daguang Wang; Chunping Li; Yuechao Xu; Yanpeng Xing; Limei Qu; Yuchen Guo; Yang Zhang; Xuan Sun; Jian Suo
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

4.  Clinicopathological characteristics of alpha-fetoprotein-producing gastric cancer.

Authors:  Huan Chun; Sung Joon Kwon
Journal:  J Gastric Cancer       Date:  2011-03-31       Impact factor: 3.720

5.  The Effectiveness of Hepatic Arterial Infusion Chemotherapy with 5-Fluorouracil/Cisplatin and Systemic Chemotherapy with Ramucirumab in Alpha-Fetoprotein-Producing Gastric Cancer with Multiple Liver Metastases.

Authors:  Yasuhiro Doi; Yasushi Takii; Kenji Mitsugi; Koichi Kimura; Yutarou Mihara
Journal:  Case Rep Oncol Med       Date:  2018-11-11

6.  miR-122-5p as a novel biomarker for alpha-fetoprotein-producing gastric cancer.

Authors:  Suguru Maruyama; Shinji Furuya; Kensuke Shiraishi; Hiroki Shimizu; Hidenori Akaike; Naohiro Hosomura; Yoshihiko Kawaguchi; Hidetake Amemiya; Hiromichi Kawaida; Makoto Sudo; Shingo Inoue; Hiroshi Kono; Daisuke Ichikawa
Journal:  World J Gastrointest Oncol       Date:  2018-10-15

7.  Prognostic value of serum alpha-fetoprotein levels in patients with gastric cancer: a meta-analysis.

Authors:  Xiang Xu; Qing Wang; Huihua Cao; Zhenyan Gao; Guangyang Qian; Qicheng Lu; Yugang Wu
Journal:  J Int Med Res       Date:  2020-03       Impact factor: 1.671

8.  Aberrant AFP expression characterizes a subset of hepatocellular carcinoma with distinct gene expression patterns and inferior prognosis.

Authors:  Wei Chen; Jianjun Peng; Jinning Ye; Weigang Dai; Guanghua Li; Yulong He
Journal:  J Cancer       Date:  2020-01-01       Impact factor: 4.207

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.